Marwan Berrada-Sounni Email & Phone Number

Santa Clara, Ca, Us

Santa Clara, California, Us

Proud to be leading Advanced NanoTherapies Inc. and helping patients access Dual-API based Drug Coated Balloons (DCB) using biodegradable nanoparticle technology for higher cellular uptake and retention.

T45 Labs is a MedTech Incubator with a fund focused on developing minimally invasive technologies that target large addressable markets in the cardiovascular sector. T45 Labs pursues a fast-follower strategy to minimize clinical and commercial risks to provide higher returns in a shorter period. The fund is a direct investment vehicle into T45 Labs portfolio companies to support Series A and Series B.

Santa Clara, California, Us

Co-founder of VahatiCor Inc. Addressing the large unmet need of refractory angina. Helping "no option" patients to have a therapeutic option.

Dijon, Fr

A Peripheral Arterial Disease start-up developing a novel device for interventional radiologists and cardiologists to minimize catheter exchange, irradiation exposure, and reduce procedural time.* Working with the product development team to shape strategy around product features for a minimally viable product (MVP).* US clinical development through connections to US physicians and hospitals. * Understanding the Voice of Customer and develop a strategy for new product such as Drug-Coated Stents and Drug-Coated Balloons.

Sunnyvale, Ca, Us

- Evaluating investment opportunity on behalf of Life Science Angels.- Deal sourcing- Investment as angel

Campbell, California, Us

Premier Medtech Incubator in the Silicon Valley. Responsible on assessing relevent unmet clinical needs in the fields of structural heart (mitral and tricuspid valve), heart failure (pressure sensing, patient management, HFpEF & HFrEF treatments), vascular medicine (CLI, Endovascular, Neurovascular), and digital health including Artificial Intelligence.Led innovation and ideation session resulting in IP generation and structure pitch deck for potential fundraising.Reviewed external opportunities for due diligence and potential Seed Round investment from ShifaMed.

Cleveland, Ohio, Us

The Global Cardiovascular Innovation Center (GCIC) is a cardiovascular product development consortium made possible through a $60 million grant from the State of Ohio. 1 - Ideation and Product Development with physicians from Cleveland Clinic Heart and Vascular Institute to identify needs, create solutions, and build relevant product in large markets. (e.g. Structural Heart, EP,...)2 - License negotiation, venture development, and start-up formation (investor attraction, seed funding, pitches, financial modeling, contract negotiation, and commercialization) for relevant Cleveland Clinic opportunities.3 - Project Director at NIH Center for Accelerated Innovations at the Cleveland Clinic, scouting and cultivating new technologies, project evaluation, coaching, mentoring, and product positioning for licensing or NewCo formation.4 - Business Development - Cleveland Clinic Innovations Pre-Clinical Services - Procedural development, Training, and Product Evaluation

Montreal, Quebec, Ca

Product Development and Strategic Consulting firm within medical device industry. Strength in catheter-based development.Board Member and Strategic Advisor.

- Grew contract R&D and managed $1.5M+ budget with P&L responsibility; report to Board of Directors. - Raised $1M seed-fund to develop aortic heart valve remodeling device; $250K from grant awards in non-dilutive government money for R&D product development (wrote both grants). - Recruited KOLs in US, Europe and Canada for participation on BMT’s Scientific Advisory Board. - Attained license from the Cleveland Clinic to commercialize a trans-septal puncture device. - Identified opportunity and managed long duration sales cycle to design and manufacture balloon based catheters

Montrea, Quebec, Ca

Project Manager (2/2006 - 8/2007)Senior R&D Engineer (4/2004 - 2/2006)- Assumed responsibility for launching 1st generation FlexCath into the European market; this deflectable sheath generated sales of $5.6M. In parallel, managed regulatory hurdles during FDA submission process. - Teamed with Marketing to develop forecast & sales plan, design research survey and conduct VOC interviews.- Led R&D team in developing an elongated balloon designed for the arteries of the leg. Managed $2.5M budget and project resources dispersed across Canada, US and Germany

Minneapolis, Minnesota, Us

Senior R&D Engineer (7/2003 - 4/2004)R&D Engineer (7/2001-7/2003)- Led redesign (rapid exchange configuration) of Distal Embolic Protection Filter extending the technology for new indications in radiology and neurology. Managed design history file; oversaw FDA and CE Mark technical testing and document submission.- Developed a drug eluding stent (based on PLLA matrix) for PAD application; established drug-loading amounts for stents to deliver required therapeutic load and designed coating-fixtures. - Among first employees and member of team that designed a Distal Embolic Protection Filter for cardiology applications; device obtained CE Mark in 2005.

Bsc., Mechanical Engineering, Graduated Magna Cum Laude

Mba, Finance - Strategy

Ms, Mechanical Engineering